An updated review current to late August 2025 assesses specialized culture media used to grow embryos during in vitro fertilization (IVF). Evaluating 26 studies involving human ART procedures, researchers found that current evidence remains largely inconclusive regarding which specific chemical solution reliably maximizes live birth rates.
This analysis evaluates what clinical data reveals—and what it fails to prove—about the various nutrient solutions utilized before uterine transfer.
In Plain English: The Clinical Takeaway
- The Solution Matters, But Data Is Thin: Embryo culture media are special solutions providing nutrients designed to help embryos grow in the laboratory.
- Most Media Show No Clear Winner: Out of 26 clinical studies reviewed, most found no clear difference between the culture media they compared.
The Clinical Mechanics of Embryo Culture Media
During standard in vitro fertilization protocols, human oocytes are retrieved and fertilized in a controlled laboratory setting. The resulting embryos must then be sustained outside the body before being transferred into the womb (uterus) or frozen for later use. To accomplish this, embryos are placed into an embryo culture medium.
These specialized solutions provide nutrients to help the embryo grow. However, because different manufacturers formulate these chemical recipes with variations, researchers have sought to determine if one specific product line improves success rates.
Evaluating the Evidence: What the 2025 Review Discovered
The updated review searched for trials comparing different human embryo culture media. Out of 26 relevant studies identified, only eight reported primary clinical endpoints such as live birth or ongoing pregnancy confirmed via ultrasound heartbeat detection. Furthermore, 60 additional studies were excluded from final data synthesis because they were published solely as short summaries without enough information.
Crucially, combining the studies’ results was rendered impossible because no two studies compared the same culture media. Within individual studies, however, two larger trials reported specific variations. One trial involving 836 women indicated that the G5 medium probably yielded a higher live birth and ongoing pregnancy rate compared to HTF. Another trial of 743 participants suggested that EmbryoAssist supplemented with low-concentration GM-CSF produced higher success metrics than a version of EmbryoAssist without the GM-CSF. Yet, investigators noted high uncertainty surrounding these figures, especially because the treatment was changed during the study.
| Comparison Evaluated | Sample Size (N) | Reported Outcome Difference | Certainty of Evidence |
|---|---|---|---|
| G5 versus HTF | 836 women (1 study) | Suggested approx. 6% higher live birth/ongoing pregnancy with G5 | Not specified |
| EmbryoAssist + GM-CSF (low HSA) vs. EmbryoAssist without GM-CSF | 743 women (1 study) | Suggested approx. 6% higher live birth/ongoing pregnancy with GM-CSF | Very uncertain |
| Other Media Comparisons | 3,315 women across 8 studies | Most studies found no clear differences | Very uncertain |
Methodological Hurdles
Many investigations suffer from small numbers of people taking part, poorly defined chemical constituents, and heterogeneous randomization protocols—such as assigning eggs or embryos rather than women to the groups being compared, or transferring embryos from different study groups to the same woman.
Contraindications & When to Consult a Doctor
Future Directions in Reproductive Laboratory Science
Resolving the debate over optimal culture media will require more well-designed studies.
References
- Cochrane Database of Systematic Reviews. Culture media for embryo development in assisted reproduction.
